Compelling evidence suggests that cognitive decline in Alzheimer’s disease is associated with the accumulation and aggregation of tau protein, with the most toxic aggregates being in the form of oligomers. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.